Profile data is unavailable for this security.
About the company
Transcenta Holding Limited is a China-based investment holding company engaged in the discovery, research, development, manufacturing and business development of biopharmaceuticals in the clinical stage. The Company's products include MSB2311, TST001, TST005, TST002, TST004, TST003, TST008, MSB0254 and TST006. The Company's all products are in the research and development (R&D) stage and have not been commercialized. The Company also provides contract developmentand manufacturing organization (CDMO) services, mainly including process development services, GMP / cGMP production services, cell line development services, sample testing services, formula optimization services and drug formation research.
- Revenue in HKD (TTM)49.49m
- Net income in HKD-1.01bn
- Incorporated2010
- Employees321.00
- LocationTranscenta Holding LimitedB6-501, Biobay, 218 Xinghu StreetSUZHOU 215123ChinaCHN
- Websitehttp://www.transcenta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Canbridge Pharmaceuticals Inc | 58.64m | -1.07bn | 1.10bn | 141.00 | -- | 1.99 | -- | 18.81 | -12.24 | -12.24 | 0.2378 | 1.30 | 0.077 | 3.60 | 4.95 | 320,429.70 | -140.88 | -- | -182.11 | -- | 63.51 | -- | -1,828.44 | -- | 3.00 | -506.82 | 0.2359 | -- | 158.98 | -- | -27.30 | -- | -- | -- |
| Genor Biopharma Holdings Ltd | 3.23m | -950.02m | 1.15bn | 452.00 | -- | 0.4955 | -- | 355.14 | -1.90 | -1.90 | 0.0065 | 4.58 | 0.001 | 0.0175 | 0.029 | 5,043.80 | -30.50 | -- | -33.43 | -- | 73.38 | -- | -29,412.99 | -- | 8.33 | -- | 0.0252 | -- | -100.00 | -- | 71.42 | -- | -- | -- |
| Hbm Holdings Ltd | 232.10m | -1.17bn | 1.19bn | 365.00 | -- | 0.9398 | -- | 5.13 | -1.59 | -1.59 | 0.3163 | 1.65 | 0.0998 | -- | 25.77 | 602,858.80 | -50.15 | -- | -57.13 | -- | 99.31 | -- | -502.40 | -- | -- | -- | 0.2826 | -- | -69.46 | -- | 53.52 | -- | -- | -- |
| Zhaoke Ophthalmology Ltd | 0.00 | -331.05m | 1.27bn | 268.00 | -- | 0.4698 | -- | -- | -0.6111 | -0.6111 | 0.00 | 4.98 | 0.00 | -- | -- | 0.00 | -11.24 | -- | -11.70 | -- | -- | -- | -- | -- | -- | -127.18 | 0.0247 | -- | -- | -- | -192.96 | -- | -- | -- |
| Golden Throat Holdings Group Co Ltd | 829.25m | 177.85m | 1.29bn | 937.00 | 7.23 | 0.8963 | 5.87 | 1.55 | 0.2406 | 0.2406 | 1.12 | 1.94 | 0.4231 | 2.58 | 3.17 | 885,003.00 | 9.07 | 8.57 | 12.64 | 12.02 | 69.69 | 72.68 | 21.45 | 18.78 | 2.38 | 159.04 | 0.1806 | 56.25 | 26.83 | 1.33 | 21.80 | 12.76 | 44.82 | 22.25 |
| Jacobson Pharma Corporation Ltd | 1.60bn | 177.67m | 1.62bn | 1.74k | 9.06 | 0.6459 | 4.27 | 1.02 | 0.0927 | 0.0927 | 0.8329 | 1.30 | 0.3316 | 2.91 | 5.60 | 919,091.60 | 3.90 | 4.96 | 5.37 | 6.88 | 38.89 | 41.41 | 11.76 | 13.74 | 1.05 | 16.36 | 0.3228 | 32.46 | 10.35 | 4.90 | 2.28 | -0.186 | -7.11 | 12.02 |
| Mabpharm Ltd | 33.29m | -287.63m | 1.69bn | 389.00 | -- | 3.15 | -- | 50.79 | -0.0697 | -0.0697 | 0.0081 | 0.13 | 0.0318 | 0.1875 | 3.98 | 68,777.45 | -27.48 | -- | -35.08 | -- | 63.71 | -- | -864.06 | -- | 0.6451 | -32.37 | 0.205 | -- | -- | -- | -58.01 | -- | -- | -- |
| Dawnrays Pharmaceutical Holdings Ltd | 1.29bn | 396.61m | 1.69bn | 1.06k | 4.30 | 0.6271 | 3.66 | 1.31 | 0.2631 | 0.2631 | 0.855 | 1.80 | 0.3839 | 2.39 | 7.00 | 1,209,992.00 | 11.72 | 11.45 | 13.95 | 13.83 | 59.26 | 58.71 | 30.53 | 29.60 | 2.31 | 20.12 | 0.0105 | 42.68 | 13.75 | 7.17 | 33.58 | 6.14 | 65.21 | 2.29 |
| JW (Cayman) Therapeutics Co Ltd | 105.71m | -929.19m | 1.70bn | 589.00 | -- | 0.5983 | -- | 16.10 | -2.29 | -2.29 | 0.2602 | 6.92 | 0.0304 | 3.11 | 2.83 | 197,963.80 | -26.67 | -- | -28.28 | -- | 33.24 | -- | -878.98 | -- | 9.74 | -10.52 | 0.0545 | -- | -- | -- | 57.79 | -- | -- | -- |
| Transcenta Holding Limited | 49.49m | -1.01bn | 1.70bn | 321.00 | -- | 0.8844 | -- | 34.39 | -2.28 | -2.28 | 0.1124 | 4.32 | 0.0194 | 1.65 | 4.56 | 136,323.00 | -39.61 | -- | -48.08 | -- | 17.48 | -- | -2,040.65 | -- | 2.63 | -47.97 | 0.1908 | -- | -37.96 | -- | -441.82 | -- | -- | -- |
| TOT Biopharm International Co Ltd | 256.86m | -176.84m | 1.73bn | 355.00 | -- | 3.88 | -- | 6.73 | -0.3074 | -0.3074 | 0.4465 | 0.5825 | 0.3254 | 1.65 | 5.40 | 762,190.20 | -22.41 | -- | -34.33 | -- | 73.14 | -- | -68.85 | -- | 0.8533 | -14.00 | 0.4296 | -- | 239.36 | -- | 9.46 | -- | -- | -- |
| Essex Bio-Technology Ltd | 1.56bn | 323.01m | 1.82bn | 1.42k | 5.86 | 1.05 | 5.06 | 1.17 | 0.5427 | 0.5427 | 2.59 | 3.04 | 0.575 | 1.87 | 3.02 | 1,128,434.00 | 11.94 | 14.05 | 15.58 | 18.53 | 87.38 | 82.63 | 20.76 | 21.20 | 2.00 | 19.46 | 0.2272 | 15.57 | 67.43 | 16.12 | 58.03 | 20.48 | 47.87 | 24.31 |
| SinoMab Bioscience Ltd | 28.30m | -346.81m | 1.91bn | 296.00 | -- | 3.00 | -- | 67.66 | -0.351 | -0.351 | 0.0286 | 0.6172 | 0.0264 | -- | -- | 99,991.95 | -32.38 | -- | -34.63 | -- | -- | -- | -1,225.57 | -- | -- | -6.78 | 0.3432 | -- | -- | -- | -135.07 | -- | -- | -- |
| Abbisko Cayman Ltd | -100.00bn | -100.00bn | 2.45bn | 192.00 | -- | 0.9038 | -- | -- | -- | -- | -- | 3.86 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 0.0204 | -- | -- | -- | -156.14 | -- | -- | -- |
| Antengene Corporation Ltd | 90.34m | -619.16m | 2.47bn | 383.00 | -- | 1.03 | -- | 27.36 | -0.9937 | -0.9937 | 0.1453 | 3.63 | 0.0307 | 2.90 | 1.68 | 274,583.60 | -21.02 | -- | -22.36 | -- | 83.94 | -- | -685.39 | -- | 11.13 | -- | 0.0156 | -- | -- | -- | 77.62 | -- | -- | -- |
| Immunotech Biopharm Ltd | 0.00 | -379.21m | 2.49bn | 267.00 | -- | 3.32 | -- | -- | -0.7369 | -0.7369 | 0.00 | 1.45 | 0.00 | -- | -- | 0.00 | -33.66 | -- | -37.53 | -- | -- | -- | -- | -- | 1.49 | -18.73 | 0.1291 | -- | -- | -- | 19.32 | -- | -- | -- |
Data as of Nov 25 2022. Currency figures normalised to Transcenta Holding Limited's reporting currency: Hong Kong Dollar HKD
8.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Fullerton Fund Management Co. Ltd.as of 29 Sep 2021 | 26.02m | 5.84% |
| Qatar Investment Authority (Investment Management)as of 28 Sep 2021 | 10.33m | 2.32% |
Data from 30 Sep 2022 - 01 Nov 2022Source: FactSet Research Systems Inc.
